Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15596-601. doi: 10.1073/pnas.242407999. Epub 2002 Nov 12.

Abstract

Diet is a major environmental source of proinflammatory AGEs (heat-generated advanced glycation end products); its impact in humans remains unclear. We explored the effects of two equivalent diets, one regular (high AGE, H-AGE) and the other with 5-fold lower AGE (L-AGE) content on inflammatory mediators of 24 diabetic subjects: 11 in a 2-week crossover and 13 in a 6-week study. After 2 weeks on H-AGE, serum AGEs increased by 64.5% (P = 0.02) and on L-AGE decreased by 30% (P = 0.02). The mononuclear cell tumor necrosis factor-alphabeta-actin mRNA ratio was 1.4 +/- 0.5 on H-AGE and 0.9 +/- 0.5 on L-AGE (P = 0.05), whereas serum vascular adhesion molecule-1 was 1,108 +/- 429 and 698 +/- 347 ngml (P = 0.01) on L- and H-AGE, respectively. After 6 weeks, peripheral blood mononuclear cell tumor necrosis factor-alpha rose by 86.3% (P = 0.006) and declined by 20% (P, not significant) on H- or L-AGE diet, respectively; C-reactive protein increased by 35% on H-AGE and decreased by 20% on L-AGE (P = 0.014), and vascular adhesion molecule-1 declined by 20% on L-AGE (P < 0.01) and increased by 4% on H-AGE. Serum AGEs were increased by 28.2% on H-AGE (P = 0.06) and reduced by 40% on L-AGE (P = 0.02), whereas AGE low density lipoprotein was increased by 32% on H-AGE and reduced by 33% on L-AGE diet (P < 0.05). Thus in diabetes, environmental (dietary) AGEs promote inflammatory mediators, leading to tissue injury. Restriction of dietary AGEs suppresses these effects.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Biomarkers
  • C-Reactive Protein / analysis
  • Cross-Over Studies
  • Diabetes Complications
  • Diabetes Mellitus / metabolism*
  • Diabetic Angiopathies / epidemiology
  • Diabetic Angiopathies / etiology*
  • Diet / adverse effects*
  • Dietary Carbohydrates / administration & dosage
  • Dietary Carbohydrates / adverse effects
  • Dietary Fats / administration & dosage
  • Dietary Fats / adverse effects
  • Dietary Proteins / administration & dosage
  • Dietary Proteins / adverse effects
  • Female
  • Food Analysis
  • Food, Formulated
  • Gene Expression Regulation / drug effects
  • Glycation End Products, Advanced / administration & dosage
  • Glycation End Products, Advanced / adverse effects*
  • Glycation End Products, Advanced / blood
  • Humans
  • Inflammation Mediators / metabolism*
  • Lipid Peroxidation
  • Lysine / adverse effects
  • Lysine / analogs & derivatives*
  • Lysine / analysis
  • Male
  • Middle Aged
  • Pyruvaldehyde / adverse effects
  • Pyruvaldehyde / analysis
  • Risk Factors
  • Tumor Necrosis Factor-alpha / analysis
  • Vascular Cell Adhesion Molecule-1 / analysis

Substances

  • Biomarkers
  • Dietary Carbohydrates
  • Dietary Fats
  • Dietary Proteins
  • Glycation End Products, Advanced
  • Inflammation Mediators
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • N(6)-carboxymethyllysine
  • Pyruvaldehyde
  • C-Reactive Protein
  • Lysine